Sharen schreef op 22 januari 2025 23:23:
[...]
Misschien leest de nieuwe CEO wel mee :-)
——translated——
I don't think loosing a few percent on the stock value as such is a disaster.
But Investors are clearly a bit fed up with Pharming only spreading detailed texts on new remuneration proposals.
They rather want Pharming to inform them about current affairs, annual turnover, cash position, targets for 2025 and VUS results.